A study led by Jenner Investigator Prof Simon Draper has identified the antibodies that may hold the key to creating the first effective vaccine against malaria infection in the blood. The researchers from the Jenner Institute along with partners from five institutions around the world, have identified the human antibodies that prevent the malaria parasite from entering blood cells, which may be key to creating a highly effective malaria vaccination. The results of the study were published today in the journal Cell.
Common Genetic Variations Associated with the Persistence of Immunity following Childhood Immunization. Cell Rep, 27 (11), pp. 3241-3253.e4. Article
Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody. Nat Microbiol. Article
Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.
If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.
Dr Vincent Munster: Ecology of emerging viruses: from host reservoir to disease, 24/Jun/2019 11:00
Prof Paul Norman, Prof Chris Gignoux: Double Seminar: 'Ancient and Modern Admixture Enhanced Natural Killer cell activity in Asia and Oceania' and 'Leveraging human genetic diversity in our study of complex trait architecture', 19/Jul/2019 11:00